Look at these brothers and sisters.
Release time:
2020-08-14
Look at these brothers and sisters
A few days ago, my mother was hospitalized with a finger injury. After leaving the hospital, relatives and neighbors came to see her.
On the first day of discharge from hospital, it was her sister-in-law who came to visit her mother. At ordinary times, young people are busy working in the fields. During the day, only the old people are at home, so they come together. The two old people are almost 80 years old, but they are hale and hearty. They talk about their brothers and sisters when they talk about their daily life. One said that his brother had more than 80 this year, and the other said that her sister had more than 70 . Then I recalled the hard days when I was young, saying that at that time, my brothers and sisters all helped each other. I gave you a bag of corn, and you carried me a bag of wheat. No one cared about who suffered and who took advantage. As long as I had it and you needed it, you would not hesitate to deliver it to the door. Now that everyone is getting old, brothers and sisters have to get together. It's not enough for them to be in good health. They have to wait for the children to pick them up and pick them up. Therefore, every time they get together, they have to stay together for several days. Even if there is no new topic discussion, they will sit together silently and accompany each other. When they separated, they were especially sad because they did not know when they would meet next.
The next day, my mother's brothers and sisters came with their children. Although the uncles live in different villages and towns with us, they heard the news of their mother's illness and made an appointment with each other by phone and WeChat. My uncle and aunt, cousin and cousin, cousin and cousin, from their twenties to their fifties, filled two tables. Knowing that it is not convenient for mothers to cook because of hand pain, women cook, boil water and cook dishes, men talk about their current life and future plans, and a large family is very happy with laughter and lively. Because we live in different places, although we always meet together when we have something, and when we encounter difficulties, we also have money to give money and no money to contribute, but in general, it is rare to get together in addition to the New Year's Day. So this time together, everyone is always chattering about endless topics.
Thinking about the gathering of these two days, I suddenly felt full of emotions-the same brothers and sisters, the changes of the times, the different ages, and the changes in the living environment have also made their lives so different. But what will not change is the affection that blood is thicker than water. Therefore, cherish our brothers and sisters, while we are still talking about the age when we can see them. (Shang Yongzhen)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31